Showing results 1 to 20 of 25
next >
| Issue Date | Title | Author(s) |
| 2020 | Association Between Multiple Lines of Active Therapy and Prognosis in Esophageal Squamous Cell Carcinoma | Yang, Ying; Jia, Jun; Sun, Zhiwei; Liu, Chuanling; Xiao, Yanjie; Yu, Jing; Du, Feng; Zhang, Xiaodong |
| 2013 | B Cell Activation Is Regulated by the Stiffness Properties of the Substrate Presenting the Antigens | Wan, Zhengpeng; Zhang, Shaosen; Fan, Yilin; Liu, Kai; Du, Feng; Davey, Angel M.; Zhang, Huiyuan; Han, Weidong; Xiong, Chunyang; Liu, Wanli |
| 2013 | B cell activation is regulated by the stiffness properties of the substrate presenting the antigens (vol 190, pg 4661, 2013) | Wan, Zhengpeng; Zhang, Shaosen; Fan, Yilin; Liu, Kai; Du, Feng; Davey, Angel M.; Zhang, Huiyuan; Han, Weidong; Xiong, Chunyang; Liu, Wanli |
| 28-Oct-2021 | Comparing Biomarkers for Predicting Pathological Responses to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Systematic Review and Meta-Analysis | Zhao, Fuxing; Huo, Xingfa; Wang, Miaozhou; Liu, Zhen; Zhao, Yi; Ren, Dengfeng; Xie, Qiqi; Liu, Zhilin; Li, Zitao; Du, Feng; Shen, Guoshuang; Zhao, Jiuda |
| 2020 | Development and Validation of an Individualized Nomogram for Predicting Survival in Patients with Esophageal Carcinoma after Resection | Du, Feng; Sun, Zhiwei; Jia, Jun; Yang, Ying; Yu, Jing; Shi, Youwu; Jia, Bo; Zhao, Jiuda; Zhang, Xiaodong |
| 20-May-2021 | Efficacy of epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes as adjuvant chemotherapy in triple-negative breast cancer: 8.1 years median follow-up on a randomized clinical trial. | Zheng, Fangchao; Du, Feng; Wang, Yongsheng; Wang, Xue; Wang, Jiayu; Yue, Jian; Ma, Fei; Fan, Ying; Xu, Binghe; Yuan, Peng |
| 2024 | Functionalized Superhydrophobic Coatings with Electro-Photothermal Effect for All-Day Durable Anti-Icing | Deng, Yuanting; Du, Feng; Chen, Zongbao; Lv, Pengyu; Yin, Zuozhu; He, Ming; Xue, Mingshan; Li, Hongyuan |
| 2024 | Functionalized Superhydrophobic Coatings with Electro-Photothermal Effect for All-Day Durable Anti-Icing | Deng, Yuanting; Du, Feng; Chen, Zongbao; Lv, Pengyu; Yin, Zuozhu; He, Ming; Xue, Mingshan; Li, Hongyuan |
| 2015 | Growing Uniform Graphene Disks and Films on Molten Glass for Heating Devices and Cell Culture | Chen, Yubin; Sun, Jingyu; Gao, Junfeng; Du, Feng; Han, Qi; Nie, Yufeng; Chen, Zhaolong; Bachmatiuk, Alicja; Priydarshi, Manish Kr.; Ma, Donglin; Song, Xiuju; Wu, Xiaosong; Xiong, Chunyang; Ruemmeli, Mark H.; Ding, Feng; Zhang, Yanfeng; Liu, Zhongfan |
| 20-May-2021 | The intra-tumor heterogeneity of ER and HER2 expression in patients with ER-positive and HER2-positive breast cancer. | Ju, Jie; Du, Feng; Gao, Songlin; Si, Yiran; Hu, Nanlin; Liu, Dongxu; Wang, Xue; Yue, Jian; Zheng, Fangchao; Kang, Yikun; Yang, Zixuan; Ma, Fei; Xu, Binghe; Yuan, Peng |
| 2014 | Is Graphene a Promising Nano-Material for Promoting Surface Modification of Implants or Scaffold Materials in Bone Tissue Engineering? | Gu, Ming; Liu, Yunsong; Chen, Tong; Du, Feng; Zhao, Xianghui; Xiong, Chunyang; Zhou, Yongsheng |
| 2016 | Liquid plasticine: controlled deformation and recovery of droplets with interfacial nanoparticle jamming | Li, Xiaoguang; Xue, Yahui; Lv, Pengyu; Lin, Hao; Du, Feng; Hu, Yueyun; Shen, Jun; Duan, Huiling |
| Nov-2021 | MXD1 is a Potential Prognostic Biomarker and Correlated With Specific Molecular Change and Tumor Microenvironment Feature in Esophageal Squamous Cell Carcinoma | Du, Feng; Dong, Dezuo; Zhang, Xiaodong; Jia, Jun |
| 2018 | Novel fluoropyrimidine-based chemotherapy for advanced well-differentiated neuroendocrine tumors: a clinical update | Zhang, Heling; Shen, Guoshuang; Zhang, Shuisheng; Du, Feng; Cao, Yang; Jiang, Jun; Zheng, Fangchao; Ma, Xinfu; Wang, Ziyi; Ren, Dengfen; Ahmad, Raees; Zhao, Fuxin; Zhao, Jiuda |
| Mar-2021 | Polymorphism of FGD4 and myelosuppression in patients with esophageal squamous cell carcinoma | Yang, Ying; Jia, Jun; Sun, Zhiwei; Liu, Chuanling; Li, Ziwei; Xiao, Yanjie; Yu, Jing; Du, Feng; Shi, Youwu; Sun, Jing; Shui, Jing; Zhang, Xiaodong |
| 2017 | Prognosis impact of clinical characteristics in patients with inoperable esophageal squamous cell carcinoma | Yang, Ying; Jia, Jun; Sun, Zhiwei; Du, Feng; Yu, Jing; Liu, Chuanling; Xiao, Yanjie; Zhang, Xiaodong |
| 10-Sep-2020 | Prognostic Nomogram for Childhood Acute Lymphoblastic Leukemia: A Comprehensive Analysis of 673 Patients | Mao, Rui; Hu, Shaoxuan; Zhang, Yuanchuan; Du, Feng; Zhang, Yu; Liu, Yanjun; Zhang, Tongtong |
| 19-Jan-2021 | The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis | Huo, Xingfa; Li, Jinming; Zhao, Fuxing; Ren, Dengfeng; Ahmad, Raees; Yuan, Xinyue; Du, Feng; Zhao, Jiuda |
| Feb-2023 | Ruthenium Metal-Organic Frameworks as Stable Nanostructures for Selective Hydrogen Production from Acetaldehyde and Water under Mild Conditions | Shen, Yangbin; Zhang, Chunmei; Du, Feng; Zhang, Ting; Zhan, Yulu; Tian, Hao; Li, Chang Ming |
| 2016 | Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors | Sun, Yongkun; Niu, Wei; Du, Feng; Du, Chunxia; Li, Shuting; Wang, Jinwan; Li, Li; Wang, Fengqing; Hao, Yu; Li, Chuan; Chi, Yihebali |
